TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive In Brief: Koprowski, Niederhuber, Engstrom Chair DCE, DCT, DCPC BSCs; Roentgen Ray Officers Named June 19, 1987
TCL Archive FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza December 26, 2014
TCL Archive “We Want Our Voices To Be Heard” Coalition Tells NCAB; Seeks Seats On Advisory Board January 1, 1993